Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas

References

• Pepper M S. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin Cancer Res 2001; 7: 462–468
   PubMed Web of Science ®Google Scholar
• Hicklin D J, Ellis L M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011–1027
   PubMed Web of Science ®Google Scholar
• Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, et al. A novel vascular endothelial growth factor VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290–298
   PubMed Web of Science ®Google Scholar
• Duff S E, Li C, Jeziorska M, Kumar S, Saunders M P, Sherlock D, O'Dwyer S T, Jayson G C. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 2003; 89: 426–430
   PubMed Web of Science ®Google Scholar
• Scavelli C, Vacca A, Pietro G D, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004; 18: 1054–1058
   PubMed Web of Science ®Google Scholar
• Mandriota S J, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banjeri S, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20: 672–682
   PubMed Web of Science ®Google Scholar
• Tsurusaki T, Kanada S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999; 80: 309–313
   PubMed Web of Science ®Google Scholar
• Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationship to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000; 6: 2431–2439
   PubMed Web of Science ®Google Scholar
• Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 2001; 85: 93–97
   PubMed Web of Science ®Google Scholar
• Scietroma C, Cianfarani F, Lacal P M, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, et al. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003; 98: 789–797
   PubMed Web of Science ®Google Scholar
• Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajanieme T, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999; 154: 1381–1390
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factor Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airline House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000; 156: 1499–1504
   PubMed Web of Science ®Google Scholar
• Streubel B, Chott A, Huber D, Exner M, Jager U, Wagner O, Schwarzinger I. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. NEJM 2004; 351: 250–259
   PubMed Web of Science ®Google Scholar
• Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 2004; 101: 1364–1374
   PubMed Web of Science ®Google Scholar
• Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003; 97: 457–464
   PubMed Web of Science ®Google Scholar
• Kojima H, Shijubo N, Yamada G, Ishizawa K, Okitsu Y, Kameoka J, Sasaki T. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer 2005; 104: 1668–1677
   PubMed Web of Science ®Google Scholar
• Juttner S, Wibmann C, Jons T. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric carcinoma. J Clin Oncol 2006; 24: 228–240
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Charnock-Jones D S, Licence D, Yanaihara A, Hastings J M, Holland C M, Emoto M, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 2003; 88: 237–244
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Charnock-Jones D S, Licence D, Yanaihara A, Hastings J M, Holland C M, Emoto M, et al. Expression of vascular endothelial growth factor (VEGF-D) and its receptor VEG receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 2003; 9: 5313–5317
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yasuoka H, Tsujimoyo M, Yang O, Imabun S, Nankara M, Nakao K, et al. Prognostic significance of vascular endothelial growth factor d in breast carcinoma with long-term follow-up. Clin Cancer Res 2003; 9: 716–721
   PubMed Web of Science ®Google Scholar
• White J D, Hewett P W, Kosuge D, McCulloch T, Enholm B C, Carmichael J, Murray J C. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002; 62: 1669–1675
   PubMed Web of Science ®Google Scholar
• Funaki H, Nishimura G, Harada S, Ninomiya I, Terada I, Fushida S, Tani T, et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Oncology 2003; 64: 416–422
   PubMed Web of Science ®Google Scholar
• George M L, Tutton M G, Janssen F, Arnaout A, Abulafi A M, Eccles S A, Swift R I. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 2001; 3: 420–427
   PubMed Web of Science ®Google Scholar
• Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, Aase K, Von Euler G, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998; 153: 103–108
   PubMed Web of Science ®Google Scholar
• Kadowaki I, Ichinohasama R, Harigae H, et al. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 2005; 130: 869–877
   PubMed Web of Science ®Google Scholar
• Achen M G, Mann G B, Stacker S A. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 2006; 94: 1355–1360
   PubMed Web of Science ®Google Scholar
• Thiele W, Sleeman J P. Tumor-induced lymphangiogenesis: a target for cancer therapy?. J Biotechnol 2006; 124: 224–241
   PubMed Web of Science ®Google Scholar